937 related articles for article (PubMed ID: 6139800)
1. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.
Man in't Veld AJ; Schalekamp MA
Postgrad Med J; 1983; 59 Suppl 3(689):140-58. PubMed ID: 6139800
[TBL] [Abstract][Full Text] [Related]
2. Antihypertensive effects of 12 beta adrenoceptor antagonists in conscious spontaneously hypertensive rats: relationship to changes in plasma renin activity, heart rate and sympathetic nerve function.
Antonaccio MJ; High J; DeForrest JM; Sybertz E
J Pharmacol Exp Ther; 1986 Jul; 238(1):378-87. PubMed ID: 2873238
[TBL] [Abstract][Full Text] [Related]
3. Haemodynamic consequences of intrinsic sympathomimetic activity and cardioselectivity in beta-blocker therapy for hypertension.
Man in 't Veld AJ; Schalekamp MA
Eur Heart J; 1983 Jul; 4 Suppl D():31-41. PubMed ID: 6137381
[TBL] [Abstract][Full Text] [Related]
4. Direct 24-hour haemodynamic monitoring after starting beta-blocker therapy: studies with pindolol in hypertension.
v d Meiracker A; Man in't Veld AJ; van Eck HR; Wenting GJ; Schalekamp MA
J Hypertens Suppl; 1984 Dec; 2(3):S581-3. PubMed ID: 6100755
[TBL] [Abstract][Full Text] [Related]
5. Haemodynamic effects of propranolol in hypertension: a review.
Tarazi RC; Dustan HP; Bravo EL
Postgrad Med J; 1976; 52 Suppl 4():92-100. PubMed ID: 787955
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects on renin release of beta adrenergic antagonists with differing properties.
Weber MA; Stokes GS; Gain JM
J Clin Invest; 1974 Dec; 54(6):1413-9. PubMed ID: 4154950
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamic and beta-adrenergic receptor adaptations during long-term beta-adrenoceptor blockade. Studies with acebutolol, atenolol, pindolol, and propranolol in hypertensive patients.
van den Meiracker AH; Man in't Veld AJ; Boomsma F; Fischberg DJ; Molinoff PB; Schalekamp MA
Circulation; 1989 Oct; 80(4):903-14. PubMed ID: 2571431
[TBL] [Abstract][Full Text] [Related]
8. Mode of action of beta-adrenergic blocking drugs in hypertension.
Prichard BN; Owens CW
Clin Physiol Biochem; 1990; 8 Suppl 2():1-10. PubMed ID: 1982756
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacological basis for the therapy of cardiovascular disease with beta-adrenoceptor blocking drugs (author's transl)].
Lemmer B
Herz; 1982 Jun; 7(3):168-78. PubMed ID: 6124492
[TBL] [Abstract][Full Text] [Related]
10. Central hemodynamics of beta-adrenoceptor blocking drugs: beta 1 selectivity versus intrinsic sympathomimetic activity.
Svendsen TL
J Cardiovasc Pharmacol; 1983; 5 Suppl 1():S21-5. PubMed ID: 6188916
[TBL] [Abstract][Full Text] [Related]
11. Sympathetic activity and presynaptic adrenoceptor function in patients with longstanding essential hypertension.
Chang PC; Kriek E; van Brummelen P
J Hypertens; 1994 Feb; 12(2):179-90. PubMed ID: 8021470
[TBL] [Abstract][Full Text] [Related]
12. [Sympathetic responsiveness and antihypertensive effect of beta-receptor blockade in essential hypertension: the effect of atenolol (author's transl)].
Philipp T; Cordes U; Distler A
Dtsch Med Wochenschr; 1977 Apr; 102(15):569-74. PubMed ID: 14816
[TBL] [Abstract][Full Text] [Related]
13. Bucindolol in essential hypertension.
Reid JL; Curzio J; Vincent J
Int J Clin Pharmacol Res; 1985; 5(5):293-301. PubMed ID: 2866166
[TBL] [Abstract][Full Text] [Related]
14. Beta blockers and renal function: a reappraisal.
Epstein M; Oster JR
J Clin Hypertens; 1985 Mar; 1(1):85-99. PubMed ID: 2873206
[TBL] [Abstract][Full Text] [Related]
15. [Plasma renin and noradrenalin levels during hypotensive therapy using acebutolol (author's transl)].
Plouin PF; Comoy E; Bohuon C; Corvol P; Ménard J
Nouv Presse Med; 1979 May; 8(23):1905-9. PubMed ID: 461152
[TBL] [Abstract][Full Text] [Related]
16. Hemodynamic and hormonal adaptations to beta-adrenoceptor blockade. A 24-hour study of acebutolol, atenolol, pindolol, and propranolol in hypertensive patients.
van den Meiracker AH; Man in 't Veld AJ; van Eck HJ; Boomsma F; Schalekamp MA
Circulation; 1988 Oct; 78(4):957-68. PubMed ID: 3048776
[TBL] [Abstract][Full Text] [Related]
17. Beta-adrenergic blockade in diuretic-treated patients with essential hypertension.
Bravo EL; Tarazi RC; Dustan HP
N Engl J Med; 1975 Jan; 292(2):66-70. PubMed ID: 234005
[TBL] [Abstract][Full Text] [Related]
18. Hemodynamic and plasma renin effects of propranolol in essential hypertension.
Mookherjee S; Eich RH; Obeid AI; Smulyan H
Arch Intern Med; 1977 Mar; 137(3):290-5. PubMed ID: 843147
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic tools for assessment of adrenergic nerve activity in human hypertension.
Ibsen H; Julius S
Fed Proc; 1984 Jan; 43(1):67-71. PubMed ID: 6317465
[TBL] [Abstract][Full Text] [Related]
20. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade.
Leenen FH; Davies RA; Fourney A
Clin Pharmacol Ther; 1998 Nov; 64(5):522-35. PubMed ID: 9834044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
